Disrupted in Renal Carcinoma 2 (DIRC2) Peptide
DIRC2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN936149
Quick Overview for Disrupted in Renal Carcinoma 2 (DIRC2) Peptide (ABIN936149)
Target
DIRC2
(Disrupted in Renal Carcinoma 2 (DIRC2))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- AAESSRAHIK DRIEAVLYAE FGVVCLIFSA TLAYFPPRPP LPPSVAAASQ
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DIRC2 antibody,
Alternative Names: DIRC2 control peptide, DIRC2 antibody Blocking Peptide, Anti-DIRC2 Blocking Peptide, Disrupted In Renal Carcinoma 2 Blocking Peptide, FLJ14784 Blocking Peptide, RCC4 Blocking Peptide, DIRC2, DIRC-2, DIRC 2, DIRC-2 Blocking Peptide, DIRC 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- DIRC2 (Disrupted in Renal Carcinoma 2 (DIRC2))
-
Background
- DIRC2 is a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of DIRC2 by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.
-
Molecular Weight
- 52 kDa
Target
-
You are here:
